Thus, the emerging protective role of the HLA-DP*04 allele is in parallel with the HLA-DR*11 allele, which is the most common in the Hellenic population, and the protective HLA-DRB1 allele in Hellenic patients with MS [11]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.